
Recently, high-power, short-duration (HPSD) strategies in radiofrequency ablation for atrial fibrillation (AF) have been shown to improve outcomes, according to Mohan Li and colleagues. Via meta-analysis, they evaluated the safety and efficacy of HPSD versus conventional settings and concluded that HPSD radiofrequency ablation demonstrated better effectiveness and consistent safety.
The analysis, published in Cardiovascular Therapeutics, reviewed 22 studies from the PubMed, Embase, and Cochrane Library databases that encompassed 3867 patients with AF. Of those patients, 2393 underwent HPSD radiofrequency ablation.
Efficacy, safety, and effectiveness end points included first-pass pulmonary vein isolation (PVI), acute pulmonary vein (PV) reconnection, freedom from AF and atrial tachycardia during follow-up, esophagus injury rate, major complication rate, complete PVI rate, total procedure time, PVI time, and PVI radiofrequency ablation (PVI RF) time.